Global Premenstrual Syndrome (PMS) Market Analysis

The global premenstrual syndrome (PMS) market is segmented by treatment into supplements and alternative treatments (non-prescribed). Many women have found these methods helpful. Often, doctors prescribe combination therapies to treat PMS. Some of the therapies used for treating premenstrual syndrome include diet, exercise, supplements, psychological therapy, and other medical treatment.

The medical treatment sector in the global premenstrual syndrome (PMS) market holds a significant share. On the basis of treatment, the medical treatment sector in the global PMS market is divided into painkillers, oral contraceptive pills, estrogen-only patches and implants, gonadotropin-releasing hormone (GnRH) analogues, and selective serotonin reuptake inhibitors (SSRIs).

The common painkillers available in the global premenstrual syndrome (PMS) market to treat PMS include paracetamol and NSAIDs. Many painkillers are available over the counter in the global premenstrual syndrome (PMS) market. SSRIs are prescribed for patients that suffer from severe PMS or premenstrual dysphoric disorder (PMDD). SSRIs such as sertraline and fluoxetine are antidepressants used to combat depression and relieve tiredness due to PMS. On the other hand, GnRH are synthetic hormones that result in a temporary menopause and are taken as an injection. GnRH is prescribed for patients that have severe PMS. The rising demand for hormone therapy-based treatment worldwide has contributed to the rise in sales of the overall global premenstrual syndrome (PMS) market by a great extent.

Several drugs aimed at treating premenstrual syndrome are in the pipeline. By stages, the global premenstrual syndrome (PMS) market’s pipeline is segmented into pre-registration phase, clinical phase, pre-clinical phase, and discovery phase. Some of the drugs in the global premenstrual syndrome (PMS) market pipeline are Dutasteride, ProgestoMat, PH80-PMD, CDB-2914, and Cis-platinum.

The key players operating in the global premenstrual syndrome (PMS) market are Pherin Pharmaceuticals, Inc., DEKK-TEC, Inc., Umecrine Mood AB, and MetP Pharma AG.

On the basis of geography, the global premenstrual syndrome (PMS) market is divided into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America and Europe are currently dominating the global premenstrual syndrome (PMS) market in terms of revenue and research activities. The availability of technologically advanced diagnostic equipment, along with development of healthcare facilities, is driving the global premenstrual syndrome (PMS) market. Presently, the two well-validated scales used for recording premenstrual symptoms are the Prospective Record of the Severity of Menstruation (PRISM) and the Calendar of Premenstrual Experience (COPE).

Asia Pacific and Rest of the World are currently the most lucrative markets for new entrants and established players due to the large female population base of these regions. Out of the total number of menstruating women, around 20-30% are considered to be affected by premenstrual syndrome. Furthermore, the rising incidence of lifestyle-related disorders is also driving these regional markets. The increasing number of government interventions and campaigns for women’s health and well-being are creating awareness about PMS and other related menstrual disorders in developing nations. This is further driving the Asia Pacific and Rest of the World premenstrual syndrome markets.

Rising awareness due to several government and non-government campaigns is expected to boost the sales of the medical drugs used to treat PMS. Furthermore, the rising availability of premenstrual syndrome medicines will propel the overall premenstrual syndrome (PMS) market.

Enquiry About This Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2922

About Us:-
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Nachiket
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030

Report this Page